A groundbreaking achievement has been reached in the fight against malaria. Novartis announced today that its revolutionary therapy has received official approval to address malaria in newborns and infants, signaling a major breakthrough in global health. This groundbreaking pharmaceutical will now be available in countries where malaria is most p